Gapping up
Select metals/mining stocks trading higher:
- RIO +3.1%, BHP +2.7%, FCX +2.4%, X +1.9%
Select oil/gas related names showing strength:
- PSX +2.8%, RDS.A +2.6%, USO +2.5%, HAL +2.5%, SLB +2.5%, XLE +1.9%, TTE +1.9%, XOM +1.8%, BP +1.7%
Other news:
- PTGX +91.7% (announced the FDA removed the full clinical hold on rusfertide clinical studies)
- ADMS +71.4% ( to be acquired by Supernus Pharmaceuticals (SUPN) for $8.10/share in cash)
- FLXN +68.7% (to be acquired by Pacira (PCRX) for $8.50 per share)
- LQDA +5.5% (announces that the US Patent Trial and Appeal Board ruled in its favor in the proceeding against ‘901 patent owned by United Therapeutics)
- AZPN +4.6% (Emerson (EMR) to accelerate software strategy to capitalize on high growth industry verticals and technology segments in transaction with AspenTec; AspenTech shareholders will receive approximately $87 per share in cash and 0.42 shares of common stock of the new AspenTech)
- BDTX +4.2% (Presents Preclinical Data on BDTX-1535)
- TPB +2.6% (FDA rescinds previously disclosed marketing denial order for Turning Point Brands' vapor products)
- CLF +1.6% (acquires Ferrous Processing and Trading Company for $775 mln)
- NIO +1.5% (reports Q3 e-scooters sales increased 58% yr/yr)
- AMWL +1.4% (files for 13,196,331 share common stock offering by selling shareholders)
- LCID +1.4% (repurchased an aggregate of 857,825 shares of Class A Common Stock from certain individuals who were directors and employees of the Company's predecessor, Atieva)
- ADVM +1% (reports clinical data on ADVM-022 at ASRS)
- VLTA +1% (announces that it has further extended its market penetration with the installation of new charging stations at Stop & Shop in Connecticut)
Analyst comments:
- CVNA +1.7% (upgraded to Outperform from Neutral at Wedbush)
- CCXI +1.3% (upgraded to Outperform from Mkt Perform at SVB Leerink)
- LLY +1.1% (upgraded to Buy from Hold at Berenberg)